Adventrx Pharmaceuticals, Inc. - Brian M. Culley

Healthcare >> CEO Interviews >> October 19, 2009

Brian M. Culley, M.A., MBA, is Chief Executive Officer and Director of Mast Therapeutics, Inc. Mr. Culley has served as Chief Executive Officer since February 2010 and as a member of the board of directors since December 2011. Previously, from January 2007 to February 2010, he served as Mast Therapeutics’ Chief Business Officer and Senior Vice President; from February 2006 to January 2007, he served as Senior Vice President, Business Development; and from December 2004 to February 2006, he served as Vice President, Business Development. From 2002 until 2004, Mr. Culley managed all strategic collaborations and licensing agreements for iTherx, Inc. — formerly Immusol, Inc. — in San Diego, where his most recent title was Director of Business Development and Marketing. From 1999 until 2000, he was a licensing and marketing associate at the University of California, San Diego, department of technology transfer and intellectual property services, and from 1996 to 1999, he was a research associate for Neurocrine Biosciences, Inc. Mr. Culley has more than 20 years of experience in the life science industry. He received a B.S. in biology from Boston College; a master’s in biochemistry from the University of California, Santa Barbara; and an MBA from The Johnson School of Business at Cornell University. Profile

TWST: Please give us a brief history of ADVENTRX.

Mr. Culley: The company is in the midst of a restart, so in many ways it has a very short history. In prior years, ADVENTRX (ANX)was engaged in

Join for free to read a longer excerpt or purchase this article

Adventrx Pharmaceuticals, Inc. – Brian M. Culley

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS